Claire Snyder

Professor

19982019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Claire Snyder is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Quality of Life Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survivors Medicine & Life Sciences
Quality of Health Care Medicine & Life Sciences
Patient Outcome Assessment Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Research Medicine & Life Sciences
Electronic Health Records Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2019

Medicine
Neoplasms
Patient Reported Outcome Measures
Patient Care Management
Patient Care

Breast cancer survivorship care plans: what are they covering and how well do they align with national guidelines?

Choi, Y., Smith, K. C., Shukla, A., Blackford, A. L., Wolff, A. C., Thorner, E., Peairs, K. S., El Ayass, W., Njoku, P., Papathakis, K., Riley, C. D., Zafman, N., Asrari, F., Camp, M., Wright, J. L., Mayonado, N. J., White, S. M. & Snyder, C. F., Jan 1 2019, (Accepted/In press) In : Breast Cancer Research and Treatment.

Research output: Contribution to journalArticle

Survival Rate
Guidelines
Breast Neoplasms
Neoplasms
Health Promotion

Change in health-related quality of life in older women after diagnosis of a small breast cancer

Euhus, D. M., Addae, J. K., Snyder, C. & Canner, J. K., Jan 1 2019, In : Cancer.

Research output: Contribution to journalArticle

Quality of Life
Breast Neoplasms
Mammography
Health Surveys
Mental Health

Interpreting and Acting on PRO Results in Clinical Practice: Lessons Learned from the PatientViewpoint System and beyond

Blackford, A. L., Wu, A. W. & Snyder, C., May 1 2019, In : Medical care. 57, p. S46-S51

Research output: Contribution to journalArticle

Needs Assessment
Quality of Life
Patient Reported Outcome Measures
Research
Interviews

A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial

Santa-Maria, C., Bardia, A., Blackford, A. L., Snyder, C., Connolly, R., Fetting, J. H., Hayes, D. F., Jeter, S. C., Miller, R. S., Nguyen, A., Quinlan, K., Rosner, G., Slater, S., Storniolo, A. M., Wolff, A. C., Zorzi, J., Henry, N. L. & Stearns, V., May 11 2018, (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-9 9 p.

Research output: Contribution to journalArticle

zoledronic acid
letrozole
Aromatase Inhibitors
exemestane
Pharmacogenetics